rubella & mumps combined vaccine (Biavax II)

Indications: 1) simultaneous immunization against mumps & rubella 2) measles-mumps-rubella vaccine (MMR) is the preferred vaccine for most children & many adults Contraindications: 1) hypersensitivity to eggs or neomycin 2) children < 1 year of age 3) pregnancy 4) immunocompromised individuals, except AIDS patients Caution: 1) women should not become pregnant within 3 months of vaccination 2) avoid immune globulin or plasma for 3 months Dosage: Children > 15 months & adults: 0.5 mL SC Injection: 1000 TCID50 each of: 1) Jeryl Lyn (B level) mumps strain grown in cell cultures of chick embryos 2) live rubella vaccine (Wistar 27/3 strain) Adverse effects: - most common (1-10%) - febrile seizures, fever, soreness, burning, stinging, allergic reactions Test interactions: - temporary suppression of TB skin reactivity Also see individual components.

Related

measles, mumps & rubella combined vaccine (MMR) rubella virus vaccine, live (Meruvax II)

References

Kaiser Permanente Northern California Regional Drug Formulary, 1998